
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings
Author(s) -
Tanakorn Apornpong,
Beatriz Grinsztejn,
Michael D. Hughes,
Justin Ritz,
Stephen J. Kerr,
Courtney V. Fletcher,
Kiat Ruxrungtham,
Catherine Godfrey,
Robert Gross,
Evelyn Hogg,
Carole Wallis,
Sharlaa Badal-Faesen,
Mina C. Hosseinipour,
Rosie Mngqbisa,
Breno Santos,
Sarita Shah,
Laura Hovind,
Sajeeda Mawlana,
Marije Van Schalkwyk,
Nuntisa Chotirosniramit,
Cecilia Kanyama,
Nagalingeswaran Kumarasamy,
Robert A. Salata,
Ann C. Collier,
Monica Gandhi,
for A study team
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002901
Subject(s) - lopinavir , atazanavir , interquartile range , ritonavir , regimen , viral load , medicine , hazard ratio , gastroenterology , reverse transcriptase inhibitor , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , confidence interval
To evaluate associations between hair antiretroviral hair concentrations as an objective, cumulative adherence metric, with self-reported adherence and virologic outcomes.